Resultados de la búsqueda 251-260 of 1097 for Urabeth

  1. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla. The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine ...

  2. Hematología y oncología pediátrica - Ensayos clínicos

    This protocol is being designed to offer testicular tissue cryopreservation to male pediatric patients (0-17 years of age) with fertility threatening medical ...

  3. Oncología (médica) - Ensayos clínicos

    This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer ...

  4. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to examine how well ascorbic acid and combination chemotherapy work in treating patients with lymphoma that has come back or does ...

  5. Oncología (médica) - Ensayos clínicos

    Also, to evaluate the feasibility of molecular characterization based on TMB and gene expression profiling (GEP) (for TIS - tumor inflammation signature) for ...

  6. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to collect vaginal and endometrial cell samples to study endometrial cancer. cfDNA Assay Prospective Observational Validation for ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...

  8. Oncología (médica) - Ensayos clínicos

    Rochester, Minn., Jacksonville, Fla. The purpose of this study is to to bring molecular risk prediction for breast cancer into the clinical arena through: the ...

  9. Oncología (médica) - Ensayos clínicos

    A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the ...

  10. Oncología (médica) - Ensayos clínicos

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status. The percentage ...